Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2006 Filed Feb 16, 2006 23:57 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 12,431 | $0.00 Strike: $42.83 | $0.00 |
DisclosureSEC source: 0001104659-06-010251 · a4.xml · derivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,431 Underlying: common shares · 12,431 shares Expires 2013-02-13 F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:57 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 14,685 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-010251 · a4.xml · derivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: common shares · 14,685 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:57 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 323 | $43.73 | $14,124.79 |
DisclosureSEC source: 0001104659-06-010251 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,344 Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:57 UTC |
LINDER GREG WVice President
|
Tax withholdingCommon shares without par value | 12,431 | $42.83 | $532,419.73 |
DisclosureSEC source: 0001104659-06-010251 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,667 Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:57 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 14,685 | $33.23 | $488,003.11 |
DisclosureSEC source: 0001104659-06-010251 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:59 UTC |
Tyree James LSenior Vice President
|
GrantOption (right to buy) · Derivative | 10,697 | $0.00 Strike: $42.83 | $0.00 |
DisclosureSEC source: 0001104659-06-010252 · a4.xml · derivative · entry 5 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,697 Underlying: common shares · 10,697 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:59 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 12,635 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-010252 · a4.xml · derivative · entry 4 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,100 Underlying: common shares · 12,635 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:59 UTC |
Tyree James LSenior Vice President
|
Tax withholdingCommon shares without par value | 10,697 | $42.83 | $458,152.51 |
DisclosureSEC source: 0001104659-06-010252 · a4.xml · nonDerivative · entry 2 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,541 Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:59 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionCommon shares without par value | 12,635 | $33.23 | $419,878.74 |
DisclosureSEC source: 0001104659-06-010252 · a4.xml · nonDerivative · entry 1 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:03 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 15,409 | $0.00 Strike: $42.83 | $0.00 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · derivative · entry 10 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,409 Underlying: common shares · 15,409 shares Expires 2013-02-13 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:03 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 18,231 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · derivative · entry 9 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: common shares · 18,231 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:03 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 15,409 | $42.83 | $659,967.47 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,623 Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:03 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 18,231 | $33.23 | $605,841.65 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:14 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
GrantOption (right to buy) · Derivative | 27,328 | $0.00 Strike: $42.83 | $0.00 |
DisclosureSEC source: 0001104659-06-010256 · a4.xml · derivative · entry 6 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,328 Underlying: common shares · 27,328 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:14 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 32,418 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-010256 · a4.xml · derivative · entry 5 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: common shares · 32,418 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:14 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
SaleCommon shares without par value | 713 | $43.70 | $31,158.10 |
DisclosureSEC source: 0001104659-06-010256 · a4.xml · nonDerivative · entry 3 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,709 Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:14 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Tax withholdingCommon shares without par value | 27,328 | $42.83 | $1,170,458.24 |
DisclosureSEC source: 0001104659-06-010256 · a4.xml · nonDerivative · entry 2 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,422 Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:14 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Exercise / conversionCommon shares without par value | 32,418 | $33.23 | $1,077,295.53 |
DisclosureSEC source: 0001104659-06-010256 · a4.xml · nonDerivative · entry 1 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2006 Filed Feb 9, 2006 21:36 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 21,102 | $0.00 Strike: $42.42 | $0.00 |
DisclosureSEC source: 0001104659-06-007423 · a4.xml · derivative · entry 8 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,102 Underlying: Common shares · 21,102 shares Expires 2013-02-13 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3 Read SEC document |
| February 07, 2006 Filed Feb 9, 2006 21:36 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 24,807 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-007423 · a4.xml · derivative · entry 7 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,281 Underlying: Common shares · 24,807 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3 Read SEC document |
| February 07, 2006 Filed Feb 9, 2006 21:36 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 21,102 | $42.42 | $895,146.84 |
DisclosureSEC source: 0001104659-06-007423 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,801 Read SEC document |
| February 07, 2006 Filed Feb 9, 2006 21:36 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 24,807 | $33.23 | $824,371.34 |
DisclosureSEC source: 0001104659-06-007423 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2006 Filed Feb 7, 2006 01:02 UTC |
FARRELL W JAMESDirector
|
PurchaseCommon shares without par value | 1,000 | $42.58 | $42,580.00 |
DisclosureSEC source: 0001104659-06-006300 · a4.xml · nonDerivative · entry 1 FARRELL W JAMES · CIK 0001021872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:10 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
GrantOption (right to buy) · Derivative | 70,249 | $0.00 Strike: $42.94 | $0.00 |
DisclosureSEC source: 0001104659-06-005671 · a4.xml · derivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,249 Underlying: common shares · 70,249 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:10 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 83,544 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-005671 · a4.xml · derivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,877 Underlying: common shares · 83,544 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:10 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
Tax withholdingCommon shares without par value | 70,249 | $42.94 | $3,016,492.06 |
DisclosureSEC source: 0001104659-06-005671 · a4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,349 Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:10 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
Exercise / conversionCommon shares without par value | 83,544 | $33.23 | $2,776,284.08 |
DisclosureSEC source: 0001104659-06-005671 · a4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC |
LIEPMANN HOLGER ASenior Vice President
|
GrantOption (right to buy) · Derivative | 17,954 | $0.00 Strike: $42.94 | $0.00 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · derivative · entry 10 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,954 Underlying: Common shares · 17,954 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 21,281 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · derivative · entry 9 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,281 Underlying: Common shares · 21,281 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,063 | $0.00 Strike: $40.93 | $0.00 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,063 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Tax withholdingCommon shares without par value | 17,954 | $42.94 | $770,944.76 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · nonDerivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,212 Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Exercise / conversionCommon shares without par value | 21,281 | $33.23 | $707,197.42 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC |
LIEPMANN HOLGER ASenior Vice President
|
SaleCommon shares without par value | 2,063 | $42.73 | $88,151.99 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,885 Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Exercise / conversionCommon shares without par value | 2,063 | $40.93 | $84,435.08 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 20:23 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,998 | $0.00 Strike: $39.92 | $0.00 |
DisclosureSEC source: 0001104659-06-005327 · a4.xml · derivative · entry 4 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,998 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 20:23 UTC |
Fiorentino Edward JSenior Vice President
|
SaleCommon shares without par value | 3,998 | $42.30 | $169,115.40 |
DisclosureSEC source: 0001104659-06-005327 · a4.xml · nonDerivative · entry 2 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,643 Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 20:23 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,998 | $39.92 | $159,611.35 |
DisclosureSEC source: 0001104659-06-005327 · a4.xml · nonDerivative · entry 1 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 20:23 UTC |
DALEY WILLIAM MDirector
|
PurchaseCommon shares without par value | 1,500 | $43.01 | $64,513.95 |
DisclosureSEC source: 0001104659-06-005328 · a4.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,389 Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:00 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,988 | $0.00 Strike: $41.38 | $0.00 |
DisclosureSEC source: 0001104659-06-005419 · a4.xml · derivative · entry 4 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,988 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:00 UTC |
LINDER GREG WVice President
|
Tax withholdingCommon Shares without par value | 2,916 | $43.00 | $125,388.00 |
DisclosureSEC source: 0001104659-06-005419 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,413 Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:00 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon Shares without par value | 2,988 | $41.38 | $123,643.44 |
DisclosureSEC source: 0001104659-06-005419 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:02 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 2,678 | $0.00 Strike: $43.00 | $0.00 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · derivative · entry 11 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,678 Underlying: common shares · 2,678 shares Expires 2007-02-13 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:02 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 4,198 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · derivative · entry 10 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 4,198 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:02 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 568 | $0.00 Strike: $20.53 | $0.00 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 568 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:02 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Tax withholdingCommon shares without par value | 2,949 | $43.00 | $126,807.00 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · nonDerivative · entry 4 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,790 Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:02 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionCommon shares without par value | 4,198 | $27.43 | $115,162.89 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:02 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionCommon shares without par value | 568 | $20.53 | $11,663.71 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:08 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 16,399 | $0.00 Strike: $38.42 | $0.00 |
DisclosureSEC source: 0001104659-06-005422 · a4.xml · derivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 16,399 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:08 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Tax withholdingCommon shares without par value | 15,199 | $43.00 | $653,557.00 |
DisclosureSEC source: 0001104659-06-005422 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,262 Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:08 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 16,399 | $38.42 | $630,034.82 |
DisclosureSEC source: 0001104659-06-005422 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.